Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of ticagrelor monotherapy vs. clopidogrel monotherapy on platelet reactivity: a randomized, crossover clinical study (SINGLE study)

Published:2022-04-05 Issue:8 Volume:33 Page:1146-1152
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

He Meijiao¹,Yan Wei¹,Zhang Yun¹,Kong Yihui¹,Han Xuejie¹,Ren Jie¹,Zhao Zhongyang¹,Liu Guangzhong¹,Shi Jing¹,Li Yue¹²³

Affiliation:

1. Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, P.R. China

2. Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, Harbin, P.R. China

3. Heilongjiang Key Laboratory for Metabolic Disorder & Cancer Related Cardiovascular Diseases, Harbin, P.R. China

Funder

National Natural Science Foundation of China

CS Optimizing Antithrombotic Research Fund

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2022.2052036

Reference35 articles.

1. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management

2. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial

3. Overview of Aspirin and Platelet Biology

4. Ticagrelor with or without Aspirin in High-Risk Patients after PCI

5. Duration of antiplatelet therapy after complex PCI in the TWILIGHT-COMPLEX trial: the Goldilocks dilemma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Treatment in Coronary Artery Disease;Current Pharmaceutical Design;2023-10

2. Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial;Platelets;2023-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3